Hussain Fazal, Chaudhri Naeem, Alfraih Feras, Aljurf Mahmoud
Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):203-210. doi: 10.1016/j.hemonc.2017.05.011. Epub 2017 Jul 19.
There is tremendous variability in size, scope, and resource requirements for registries depending on the number of patients and participating sites. The outcome registries are organized systems to collect uniform data using an observational study methodology. Patient registries are used to determine specified outcomes for a population for predetermined scientific, clinical, or policy purposes. Historically, outcome registries established in the development of hematopoietic stem cell transplantation (HSCT) have now evolved into myriads of locoregional and international transplant activity and outcome resources. Over time, these registries have contributed immensely in determining trends, patterns, and treatment outcomes in HSCT. There is wider variation in the goals, mission, objectives, and outcomes of the ongoing registries depending on the organizational structure. There is a growing trend toward overarching relationship of these registries to serve as complementary and interoperable resources for high potential collaborative research. In addition to capacity building, standardized, accredited, and optimally operational registries can provide unmatched and unparalleled research data that cannot be obtained otherwise. Moving forward, HSCT data collection, collation, and interpretation should be an integral part of the treatment rather than an option. Quality assurance and continuous quality improvement of the data are pivotal for credibility, measurable/quantifiable outcomes, clinically significant impact, and setting new benchmarks.
根据患者数量和参与站点的不同,登记处的规模、范围和资源需求存在巨大差异。结局登记处是使用观察性研究方法收集统一数据的有组织系统。患者登记处用于为特定人群确定预定科学、临床或政策目的的特定结局。从历史上看,造血干细胞移植(HSCT)发展过程中建立的结局登记处如今已演变成众多局部和国际移植活动及结局资源。随着时间的推移,这些登记处对确定HSCT的趋势、模式和治疗结局做出了巨大贡献。根据组织结构的不同,现行登记处的目标、使命、目的和结局存在更广泛的差异。这些登记处之间建立总体关系以作为高潜力合作研究的互补且可互操作资源的趋势日益增强。除了能力建设外,标准化、经认证且运行最佳的登记处能够提供通过其他方式无法获得的无与伦比的研究数据。展望未来,HSCT数据的收集、整理和解读应成为治疗的一个组成部分,而非一种选择。数据的质量保证和持续质量改进对于可信度、可测量/可量化的结局、临床显著影响以及设定新基准至关重要。